5-HT3 Receptors in the Central Nervous System

[1]  A Butler,et al.  Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors , 1988, British journal of pharmacology.

[2]  B. Costall,et al.  The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist , 1988, British journal of pharmacology.

[3]  Gavin Kilpatrick,et al.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding , 1987, Nature.

[4]  B. Costall,et al.  Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain , 1987, British journal of pharmacology.

[5]  Julia M. Hill,et al.  Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain. , 1987, European journal of pharmacology.

[6]  B. Costall,et al.  Actions of sulpiride and tiapride in a simple model of anxiety in mice , 1987, Neuropharmacology.

[7]  M. B. Tyers,et al.  Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve , 1987, British journal of pharmacology.

[8]  S. Iversen,et al.  Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area , 1986, Brain Research.

[9]  G. Engel,et al.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs , 1985, Nature.

[10]  S. Snyder,et al.  Two distinct central serotonin receptors with different physiological functions. , 1981, Science.

[11]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.